Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
TSX:MRV
Price:
1.35 CAD
Market Closed
Updated:
May 5, 2024
Nuvo Pharmaceuticals Inc
Cash from Operating Activities
|
Nuvo Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison
Comparables:
BHC
WEED
CRON
C
CURA
T
TER
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
Cash from Operating Activities
CA$15.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Cash from Operating Activities
$1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Cash from Operating Activities
-CA$399.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Cash from Operating Activities
-$42.8m
|
CAGR 3-Years
33%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Cash from Operating Activities
$56.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Cash from Operating Activities
-$26.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuvo Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
15.5m
CAD
15.5m
CAD
Based on the financial report for Sep 30, 2022, Nuvo Pharmaceuticals Inc's Cash from Operating Activities amounts to 15.5m CAD.
What is Nuvo Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
62%
62%
Over the last year, the Cash from Operating Activities growth was -32%.
You don't have any saved screeners yet
